Study links Avandia to heart, death risks

12/12/2007 | NYTimes.com

Diabetes patients who used the drug Avandia had a 30% increased risk of death, a 40% increased risk of heart attacks and a 60% increased risk of heart failure, compared to patients using other medicines, an independent analysis found. Cardiologist Dr. Steven E. Nissen says the findings could lead the FDA to take additional action, but the FDA says the recent information will not change current recommendations for the drug.

View Full Article in:

NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN